Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)
Condition(s):Mouth NeoplasmsLast Updated:September 8, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Mouth NeoplasmsLast Updated:September 8, 2023Recruiting
Condition(s):Actinic Keratosis; Organ or Tissue Transplant; ComplicationsLast Updated:March 15, 2022Terminated
Condition(s):Oral Cancer; Diagnoses DiseaseLast Updated:May 25, 2022Recruiting
Condition(s):Lip and Oral Cavity Squamous Cell Carcinoma; Oral Cavity Verrucous Carcinoma; Precancerous ConditionLast Updated:January 14, 2021Completed
Condition(s):Precancerous Conditions; CarcinomaLast Updated:March 1, 2018Completed
Condition(s):Carcinoma, Renal Cell; Von Hippel-Lindau DiseaseLast Updated:January 10, 2024Recruiting
Condition(s):Tumors or Premalignant LesionsLast Updated:February 21, 2021Completed
Condition(s):Erythroplakia; Leukoplakia; Oral Cavity Carcinoma; Proliferative Verrucous LeukoplakiaLast Updated:March 1, 2024Active, not recruiting
Condition(s):Lung Cancer; Precancerous ConditionLast Updated:March 9, 2012Completed
Condition(s):Ovarian Epithelial CancerLast Updated:February 25, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.